4 Results for "

autophagy-lysosome fusion

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "autophagy-lysosome fusion" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-124582
CAS No.: 1361198-80-2
Purity:  ≥98.0%
Target:  

Autophagy mTOR

Research Areas:  

Cancer

NEO214 is an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram (HY-16900) and perillyl alcohol (HY-N7000). It has anti-cancer activity and blood-brain barrier (BBB) permeability. Over sex. NEO214 prevents autophagy-lysosome fusion, thereby blocking autophagic flux and triggering glioma cell death. The process involves mTOR activation, andTFEB(Transcription Factor EB) aggregation. NEO214 inhibitionMacroautophagy/autophagy in glioblastoma cells has the potential to overcome chemotherapy resistance in glioblastoma .
loading...
    loading...
Cat. No.: HY-169364
Target:  

AUTACs PD-1/PD-L1

Research Areas:  

Cancer

2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc serves as the PD-L1 ligand-linker conjugate of AUTAC PDL1 degrader-2 (HY-169363). 2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc is applicable to AUTAC synthesis. It is also used in the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-184158
HATC is a HIF-1α AUTAC degrader. HATC links HIF-1α to LC3 to form a ternary complex that undergoes degradation via the autophagy-lysosome fusion pathway. HATC induces dose-dependent HIF-1α degradation in multiple cell types. HATC reduces visceral fat accumulation, hepatic lipid deposition, senescent cell aggregation, and bone loss; alleviates age-related intervertebral disc degeneration, liver dysfunction, kyphosis, and alveolar dilation; decreases circulating lactic acid levels; improves physical performance; and reverses age-related changes in granulocyte proportions. HATC extends median and maximum lifespan, reduces transcriptomic age, and causes no obvious persistent toxicity. HATC can be used in the research of age-related diseases (pink: LC3 ligand (HY-50759); blue: HIF-1α ligand (HY-P10426); Linker: (HY-W008264)) .
loading...
    loading...
Cat. No.: HY-181895
Target:  

HyT RET

Research Areas:  

Cancer

RET degrader-1 is a HyT degrader targeting RET. RET degrader-1 induces the degradation of CCDC6-RET via the ubiquitin-proteasome pathway. RET degrader-1 can be used in the research of RET-driven cancers .
loading...
    loading...